Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
203 EUR | -3.20% | +3.31% | -15.24% |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.24% | 21.12B | |
-3.72% | 184B | |
-2.60% | 107B | |
-3.79% | 67.78B | |
+2.66% | 50.66B | |
+16.39% | 47.64B | |
+4.60% | 41.12B | |
+1.38% | 26.3B | |
+1.52% | 26.04B | |
-1.17% | 24.71B |
- Stock Market
- Equities
- DIM Stock
- News Sartorius Stedim Biotech
- Berenberg: Sartorius Stedim Investors Await 'Several Strong Quarters' for Confidence Boost